It starts with a modification. You stop running and switch to cycling because your knees protest on impact. You drop the overhead press from your program because your shoulder catches at the top of the movement. You skip the back nine because your elbow throbs for days after eighteen holes. You tell yourself you are being smart — training around the problem, adapting, managing. But each adaptation is a concession. Each modification narrows the range of activities your body can perform without complaint. The capacity you are losing is not dramatic enough to notice week to week, but compounded over months and years, it represents a fundamental erosion of the physical autonomy that defines how you move through the world.
Men are conditioned to absorb joint pain as a cost of an active life. The assumption is that worn cartilage, inflamed tendons, and degraded synovial fluid are inevitable consequences of age and use. But the biology tells a different story. Articular cartilage has limited blood supply, which means it lacks the vascular infrastructure required for efficient self-repair. When cartilage sustains damage — whether from acute injury, repetitive stress, or the cumulative mechanical load of decades of training — the body’s natural healing response is inadequate. Inflammatory cytokines accumulate in the joint space, further degrading cartilage matrix and reducing synovial fluid viscosity. The joint becomes less lubricated, less cushioned, and less tolerant of load. Each session compounds the damage because the repair rate cannot keep pace with the wear rate.
The conventional medical approach addresses this cascade through suppression rather than regeneration. Cortisone injections reduce inflammation temporarily but do not rebuild tissue — and repeated cortisone exposure has been shown to accelerate cartilage degeneration over time. Non-steroidal anti-inflammatory drugs mask pain signals without addressing structural damage, allowing men to continue loading compromised joints while the underlying pathology progresses. Surgical intervention — arthroscopy, joint replacement — carries significant recovery timelines, infection risk, and the fundamental limitation that mechanical hardware does not replicate the adaptive, self-maintaining properties of biological tissue. The conventional model manages symptoms. It does not restore the joint’s regenerative capacity.
Platelet-rich plasma therapy operates on a fundamentally different principle. Rather than suppressing the inflammatory signal or replacing the joint mechanically, PRP concentrates your body’s own growth factors and delivers them directly to the site of degeneration — stimulating the biological repair processes that the joint’s limited vascularity cannot sustain on its own. This is not pain management. This is tissue regeneration protocol.
